TrialJournal of psychopharmacology (Oxford, England)2016

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.

Roland R Griffiths et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.